CSF2 and neoplasm: In a total of 12 patients, combined cryoablation with granulocyte macrophage colony-stimulating factor (GM-CSF) treatment was suggested to be an alternative treatment for metastatic hormone refractory prostate cancer and could induce tumor-specific T cell responses 83.